BACKGROUND: Multiple genetic loci have been associated with blood lipid levels. We tested the hypothesis that persons with an unfavorable lipid gene profile would experience a greater increase in lipid levels and a higher incidence of abnormal lipid levels relative to those with more-favorable lipid gene profiles. METHODS AND RESULTS: A total of 9328 individuals of European descent (aged 45-64 years) in the ARIC (Atherosclerosis Risk in Communities) study were followed for 9 years. Separate gene scores were created for each lipid phenotype on the basis of 95 loci identified in a published genome-wide association study of >100 000 people of European-descent. Adjusted linear and survival models were used to estimate associations with lipid levels and incidence of lipid-lowering medication or abnormal lipid levels. Age and sex interactions were also explored. The cross-sectional difference (mg/dL) per 1 SD was -1.89 for high-density lipoprotein cholesterol (HDL-C), 9.5 for low-density lipoprotein cholesterol (LDL-C), and 22.8 for triglycerides (P<5×10(-34) for all). Longitudinally, overall triglyceride levels rose over time, and each 1-SD greater triglyceride gene score was associated with an average increase in triglyceride levels of 0.3 mg/dL (P=0.003) over 3 years. The HDL-C, LDL-C, and total cholesterol gene scores were not related to change. All lipid gene scores were positively related to incidence of abnormal lipid levels over follow-up (hazard ratios per SD range, 1.15-1.36). CONCLUSIONS: Associations of genetic variants with lipid levels over time are complex. The triglyceride gene score was positively related to change in triglycerides levels, but similar longitudinal results were not observed for LDL-C or HDL-C levels. Unfavorable gene scores were nevertheless related to higher incidence of abnormal levels.
BACKGROUND: Multiple genetic loci have been associated with blood lipid levels. We tested the hypothesis that persons with an unfavorable lipid gene profile would experience a greater increase in lipid levels and a higher incidence of abnormal lipid levels relative to those with more-favorable lipid gene profiles. METHODS AND RESULTS: A total of 9328 individuals of European descent (aged 45-64 years) in the ARIC (Atherosclerosis Risk in Communities) study were followed for 9 years. Separate gene scores were created for each lipid phenotype on the basis of 95 loci identified in a published genome-wide association study of >100 000 people of European-descent. Adjusted linear and survival models were used to estimate associations with lipid levels and incidence of lipid-lowering medication or abnormal lipid levels. Age and sex interactions were also explored. The cross-sectional difference (mg/dL) per 1 SD was -1.89 for high-density lipoprotein cholesterol (HDL-C), 9.5 for low-density lipoprotein cholesterol (LDL-C), and 22.8 for triglycerides (P<5×10(-34) for all). Longitudinally, overall triglyceride levels rose over time, and each 1-SD greater triglyceride gene score was associated with an average increase in triglyceride levels of 0.3 mg/dL (P=0.003) over 3 years. The HDL-C, LDL-C, and total cholesterol gene scores were not related to change. All lipid gene scores were positively related to incidence of abnormal lipid levels over follow-up (hazard ratios per SD range, 1.15-1.36). CONCLUSIONS: Associations of genetic variants with lipid levels over time are complex. The triglyceride gene score was positively related to change in triglycerides levels, but similar longitudinal results were not observed for LDL-C or HDL-C levels. Unfavorable gene scores were nevertheless related to higher incidence of abnormal levels.
Authors: Laura J Rasmussen-Torvik; Alvaro Alonso; Man Li; Wen Kao; Anna Köttgen; Yu Yan; David Couper; Eric Boerwinkle; Suzette J Bielinski; James S Pankow Journal: Genet Epidemiol Date: 2010-11 Impact factor: 2.135
Authors: Pamela L Lutsey; Mary R Rooney; Aaron R Folsom; Erin D Michos; Alvaro Alonso; Weihong Tang Journal: Vasc Med Date: 2018-02-05 Impact factor: 3.239
Authors: Kamil F Faridi; Di Zhao; Seth S Martin; Joshua R Lupton; Steven R Jones; Eliseo Guallar; Christie M Ballantyne; Pamela L Lutsey; Erin D Michos Journal: Nutrition Date: 2017-02-03 Impact factor: 4.008
Authors: Ardashel Latsuzbaia; Vincent W V Jaddoe; Albert Hofman; Oscar H Franco; Janine F Felix Journal: J Lipid Res Date: 2016-10-24 Impact factor: 5.922
Authors: Johanne M Justesen; Ehm A Andersson; Kristine H Allin; Camilla H Sandholt; Torben Jørgensen; Allan Linneberg; Marit E Jørgensen; Torben Hansen; Oluf Pedersen; Niels Grarup Journal: J Lipid Res Date: 2016-10-24 Impact factor: 5.922
Authors: Keattiyoat Wattanakit; Pamela L Lutsey; Elizabeth J Bell; Heather Gornik; Mary Cushman; Susan R Heckbert; Wayne D Rosamond; Aaron R Folsom Journal: Thromb Haemost Date: 2012-07-10 Impact factor: 5.249
Authors: Katherine P Liao; Dorothée Diogo; Jing Cui; Tianxi Cai; Yukinori Okada; Vivian S Gainer; Shawn N Murphy; Namrata Gupta; Daniel Mirel; Ashwin N Ananthakrishnan; Peter Szolovits; Stanley Y Shaw; Soumya Raychaudhuri; Susanne Churchill; Isaac Kohane; Elizabeth W Karlson; Robert M Plenge Journal: Ann Rheum Dis Date: 2013-05-28 Impact factor: 19.103
Authors: Tibor V Varga; Azra Kurbasic; Mattias Aine; Pontus Eriksson; Ashfaq Ali; George Hindy; Stefan Gustafsson; Jian'an Luan; Dmitry Shungin; Yan Chen; Christina-Alexandra Schulz; Peter M Nilsson; Göran Hallmans; Inês Barroso; Panos Deloukas; Claudia Langenberg; Robert A Scott; Nicholas J Wareham; Lars Lind; Erik Ingelsson; Olle Melander; Marju Orho-Melander; Frida Renström; Paul W Franks Journal: Int J Epidemiol Date: 2017-08-01 Impact factor: 7.196
Authors: Tibor V Varga; Emily Sonestedt; Dmitry Shungin; Robert W Koivula; Göran Hallmans; Stefan A Escher; Inês Barroso; Peter Nilsson; Olle Melander; Marju Orho-Melander; Frida Renström; Paul W Franks Journal: PLoS Genet Date: 2014-06-12 Impact factor: 5.917